{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:28:00Z","timestamp":1768678080884,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40119-021-00212-y","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T17:41:11Z","timestamp":1613842871000},"page":"211-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Disease Management and Outcomes in Patients Hospitalized for Acute Heart Failure in Japan"],"prefix":"10.1007","volume":"10","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raluca","family":"Ionescu-Ittu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hela","family":"Romdhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Borentain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Friend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,20]]},"reference":[{"issue":"5","key":"212_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","volume":"14","author":"S Kurmani","year":"2017","unstructured":"Kurmani S, Squire I. Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep. 2017;14(5):385\u201392.","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"212_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ehf2.12305","volume":"5","author":"TD Tanaka","year":"2018","unstructured":"Tanaka TD, Sawano M, Ramani R, Friedman M, Kohsaka S. Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence. ESC Heart Fail. 2018;5(5):931\u201347.","journal-title":"ESC Heart Fail."},{"issue":"10","key":"212_CR3","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- digest version. Circ J. 2019;83(10):2084\u2013184.","journal-title":"Circ J"},{"issue":"6A","key":"212_CR4","doi-asserted-by":"publisher","first-page":"1G","DOI":"10.1016\/j.amjcard.2005.07.014","volume":"96","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Mebazaa A. Introduction to acute heart failure syndromes. Am J Cardiol. 2005;96(6A):1G-4G.","journal-title":"Am J Cardiol"},{"issue":"6A","key":"212_CR5","doi-asserted-by":"publisher","first-page":"86G","DOI":"10.1016\/j.amjcard.2005.07.026","volume":"96","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Mebazaa A. The challenge of acute heart failure syndromes. Am J Cardiol. 2005;96(6A):86G-G89.","journal-title":"Am J Cardiol"},{"issue":"02","key":"212_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4236\/wjcd.2013.32A002","volume":"3","author":"MA Valente","year":"2013","unstructured":"Valente MA, Voors AA. Renal effects of vasodilators in acute heart failure. World J Cardiovasc Dis. 2013;3(02):8.","journal-title":"World J Cardiovasc Dis"},{"issue":"12","key":"212_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"212_CR8","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","volume":"52","author":"JE Blair","year":"2008","unstructured":"Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008;52(20):1640\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"212_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ejhf.92","volume":"16","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Cotter G, Cleland JG, Stevens SR, Chiswell K, Davison BA, et al. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. Eur J Heart Fail. 2014;16(6):614\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"212_CR10","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","volume":"82","author":"H Yaku","year":"2018","unstructured":"Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, et al. Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan\u2014observations from the prospective, multicenter Kyoto Congestive Heart Failure (KCHF) Registry. Circ J. 2018;82(11):2811\u20139.","journal-title":"Circ J"},{"issue":"18","key":"212_CR11","doi-asserted-by":"publisher","first-page":"e008687","DOI":"10.1161\/JAHA.118.008687","volume":"7","author":"Y Shiraishi","year":"2018","unstructured":"Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-Year trend in the management of acute heart failure in japan: a report from the national consortium of acute heart failure registries. J Am Heart Assoc. 2018;7(18):e008687.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"212_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, Committee ASA, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47(1):76\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"212_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijcard.2017.04.078","volume":"241","author":"A Mizuno","year":"2017","unstructured":"Mizuno A, Iguchi H, Sawada Y, Hurley M, Nomura H, Hayashi K, et al. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: high value care vs. low value care campaign in Japan. Int J Cardiol. 2017;241:243\u20138.","journal-title":"Int J Cardiol"},{"issue":"11","key":"212_CR14","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1253\/circj.CJ-16-0196","volume":"80","author":"S Yasuda","year":"2016","unstructured":"Yasuda S, Nakao K, Nishimura K, Miyamoto Y, Sumita Y, Shishido T, et al. The current status of cardiovascular medicine in Japan\u2014analysis of a large number of health records from a Nationwide Claim-Based Database. JROAD-DPC Circ J. 2016;80(11):2327\u201335.","journal-title":"JROAD-DPC Circ J"},{"key":"212_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2019.01.049","volume":"280","author":"T Nagai","year":"2019","unstructured":"Nagai T, Iwakami N, Nakai M, Nishimura K, Sumita Y, Mizuno A, et al. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: Insight from a nationwide claim-based database. Int J Cardiol. 2019;280:104\u20139.","journal-title":"Int J Cardiol"},{"issue":"18","key":"212_CR16","doi-asserted-by":"publisher","first-page":"e012282","DOI":"10.1161\/JAHA.119.012282","volume":"8","author":"K Kanaoka","year":"2019","unstructured":"Kanaoka K, Okayama S, Nakai M, Sumita Y, Onoue K, Soeda T, et al. Number of cardiologists per cardiovascular beds and in-hospital mortality for acute heart failure: a nationwide study in Japan. J Am Heart Assoc. 2019;8(18):e012282.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"212_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jjcc.2019.09.008","volume":"75","author":"M Konishi","year":"2020","unstructured":"Konishi M, Matsuzawa Y, Ebina T, Kosuge M, Gohbara M, Nishimura K, et al. Impact of population density on mortality in patients hospitalized for heart failure\u2014JROAD-DPC registry analysis. J Cardiol. 2020;75(4):447\u201353.","journal-title":"J Cardiol."},{"issue":"3","key":"212_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ehf2.12418","volume":"6","author":"T Shiga","year":"2019","unstructured":"Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475\u201386.","journal-title":"ESC Heart Fail"},{"key":"212_CR19","doi-asserted-by":"crossref","unstructured":"JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012). Circ J. 2014; 78(8):2022\u201393.","DOI":"10.1253\/circj.CJ-66-0094"},{"key":"212_CR20","unstructured":"Medical Vision Data. https:\/\/www.mdv.co.jp\/solution\/pharmaceutical\/english\/. Accessed 7 Nov 2019."},{"issue":"6","key":"212_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"25","key":"212_CR22","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","volume":"69","author":"Y Matsue","year":"2017","unstructured":"Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(25):3042\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"212_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12872-015-0127-9","volume":"15","author":"H Aizawa","year":"2015","unstructured":"Aizawa H, Imai S, Fushimi K. Factors associated with 30-day readmission of patients with heart failure from a Japanese administrative database. BMC Cardiovasc Disord. 2015;15:134.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"212_CR24","doi-asserted-by":"publisher","first-page":"e013753","DOI":"10.1136\/bmjopen-2016-013753","volume":"7","author":"N Sasaki","year":"2017","unstructured":"Sasaki N, Kunisawa S, Ikai H, Imanaka Y. Differences between determinants of in-hospital mortality and hospitalisation costs for patients with acute heart failure: a nationwide observational study from Japan. BMJ Open. 2017;7(3):e013753.","journal-title":"BMJ Open"},{"issue":"4","key":"212_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1253\/circj.CJ-13-0187","volume":"77","author":"N Sato","year":"2013","unstructured":"Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J. 2013;77(4):944\u201351.","journal-title":"Circ J"},{"issue":"11","key":"212_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jchf.2020.05.013","volume":"8","author":"S Greene","year":"2020","unstructured":"Greene S, Triana T, Ionescu-Ittu R, Burne R, Gu\u00e9rin A, Borentain M, et al. In-hospital therapy for heart failure with reduced ejection fraction in the United States. JACC Heart Fail. 2020;8(11):943\u201353.","journal-title":"JACC Heart Fail"},{"key":"212_CR27","unstructured":"Sakamoto H, Rahman M, Nomura S, Okamoto E, Koike S, Yasunaga H, et al. Japan health system review. World Health Organization. Regional Office for South-East Asia. License: CC BY-NC-SA 3.0 IGO. Health Systems in Transition Vol. 8 No. 1 2018. https:\/\/apps.who.int\/iris\/handle\/10665\/259941."},{"issue":"5","key":"212_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.pcad.2013.12.001","volume":"56","author":"Y Goto","year":"2014","unstructured":"Goto Y. Current state of cardiac rehabilitation in Japan. Prog Cardiovasc Dis. 2014;56(5):557\u201362.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"212_CR29","doi-asserted-by":"publisher","first-page":"e000811","DOI":"10.1136\/openhrt-2018-000811","volume":"5","author":"T Nagai","year":"2018","unstructured":"Nagai T, Sundaram V, Rothnie K, Quint JK, Shoaib A, Shiraishi Y, et al. Mortality after admission for heart failure in the UK compared with Japan. Open Heart. 2018;5(2):e000811.","journal-title":"Open Heart"},{"issue":"9797","key":"212_CR30","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(11)60987-2","volume":"378","author":"H Hashimoto","year":"2011","unstructured":"Hashimoto H, Ikegami N, Shibuya K, Izumida N, Noguchi H, Yasunaga H, et al. Cost containment and quality of care in Japan: is there a trade-off? Lancet. 2011;378(9797):1174\u201382.","journal-title":"Lancet"},{"issue":"4","key":"212_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1388-9842(03)00003-5","volume":"5","author":"SP McKee","year":"2003","unstructured":"McKee SP, Leslie SJ, LeMaitre JP, Webb DJ, Denvir MA. Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail. 2003;5(4):549\u201355.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"212_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/CRD.0000000000000207","volume":"27","author":"C Hoorn","year":"2019","unstructured":"Hoorn C, Crijns H, Dierick-van Daele A, Dekker L. Review on factors influencing physician guideline adherence in cardiology. Cardiol Rev. 2019;27(2):80\u20136.","journal-title":"Cardiol Rev"},{"issue":"11","key":"212_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cardfail.2015.05.007","volume":"21","author":"Y Matsue","year":"2015","unstructured":"Matsue Y, Kagiyama N, Yoshida K, Kume T, Okura H, Suzuki M, et al. Carperitide is associated with increased in-hospital mortality in acute heart failure: a propensity score-matched analysis. J Card Fail. 2015;21(11):859\u201364.","journal-title":"J Card Fail"},{"issue":"11","key":"212_CR34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","volume":"72","author":"N Hata","year":"2008","unstructured":"Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J. 2008;72(11):1787\u201393.","journal-title":"Circ J"},{"key":"212_CR35","unstructured":"The Japanese Circulation Society\/The Japanese Heart Failure Society: Statement of proper use of vasopressin V2 receptor antagonist (Japanese). 2013. https:\/\/asas.or.jp\/jhfs\/pdf\/20131021_statement.pdf (asas.or.jp)."},{"issue":"4","key":"212_CR36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1253\/circj.CJ-13-1255","volume":"78","author":"A Shirakabe","year":"2014","unstructured":"Shirakabe A, Hata N, Yamamoto M, Kobayashi N, Shinada T, Tomita K, et al. Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure. Circ J. 2014;78(4):911\u201321.","journal-title":"Circ J"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-021-00212-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T03:45:15Z","timestamp":1621223115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-021-00212-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s40119-021-00212-y","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,20]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}